Publications by authors named "David Vidal"

Claim this Profile
I
Impact of carotid artery sectioning on cerebral blood flow in bovines: a numerical hemodynamic study.
Asher Benchimol, Thomas Parmentier, Jacob Hascalovici, David Vidal

Am J Vet Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eliminating the AI digital divide by building local capacity.
Freya Gulamali, Jee Young Kim, Kartik Pejavara, Ciera Thomas, Varoon Mathur, David Vidal

PLOS Digit Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aligning AI principles and healthcare delivery organization best practices to navigate the shifting regulatory landscape.
Alifia Hasan, Noah Prizant, Jee Young Kim, Shreya Rao, David Vidal

NPJ Digit Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Artificial Intelligence Algorithms in the Radiology Workflow: Challenges and Considerations.
Panagiotis Korfiatis, Timothy L Kline, Holly M Meyer, Sana Khalid, Timothy Leiner, David E Vidal

Mayo Clin Proc Digit Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.
Antonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco, Mar Llamas-Velasco, Eva V Rull, David Vidal

Int J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embedding Internal Accountability Into Health Care Institutions for Safe, Effective, and Ethical Implementation of Artificial Intelligence Into Medical Practice: A Mayo Clinic Case Study.
Brenna Loufek, David Vidal, David S McClintock, Mark Lifson, Eric Williamson

Mayo Clin Proc Digit Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening the use of artificial intelligence within healthcare delivery organizations: balancing regulatory compliance and patient safety.
Mark P Sendak, Vincent X Liu, Ashley Beecy, David E Vidal, Keo Shaw

J Am Med Inform Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empowering US healthcare delivery organizations: Cultivating a community of practice to harness AI and advance health equity.
Mark P Sendak, Jee Young Kim, Alifia Hasan, Will Ratliff, Mark A Lifson, David E Vidal

PLOS Digit Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AImedReport: A Prototype Tool to Facilitate Research Reporting and Translation of Artificial Intelligence Technologies in Health Care.
Tracey A Brereton, Momin M Malik, Lauren M Rost, Joshua W Ohde, Lu Zheng, David Vidal

Mayo Clin Proc Digit Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preliminary testing of Health Equity Across the AI Lifecycle (HEAAL): A framework for healthcare delivery organizations to mitigate the risk of AI solutions worsening health inequities.
Jee Young Kim, Alifia Hasan, Katherine C Kellogg, William Ratliff, Sara G Murray, David E Vidal

PLOS Digit Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Esteban Daudén, Elena Escario, Luisa Martos-Cabrera, Susana Armesto, Enrique Herrera-Acosta, David Vidal

Int J Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing quality management systems to close the AI translation gap and facilitate safe, ethical, and effective health AI solutions.
Shauna M Overgaard, Megan G Graham, Tracey Brereton, Michael J Pencina, John D Halamka, David E Vidal

NPJ Digit Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical Medical Principles Applied to the Future of Artificial Intelligence Software.
Eric Klavetter, Jessica Cruz, Stephanie Daniels, Nahid Y Vidal, David E Vidal

Mayo Clin Proc Digit Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence in medicine - dermatology compared to other medical specialties in FDA-cleared software as medical device.
Nahid Y Vidal, Kirk Sidey, Yong-Hun Kim, David E Vidal

Dermatol Online J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting.
Luisa Martos-Cabrera, Mar Llamas-Velasco, Susana Armesto, Enrique Herrera-Acosta, David Vidal

Int J Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating US Regulation of Artificial Intelligence in Medicine-A Primer for Physicians.
David E Vidal, Brenna Loufek, Yong-Hun Kim, Nahid Y Vidal

Mayo Clin Proc Digit Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Surfacing best practices for AI software development and integration in healthcare.
Mark Sendak, David Vidal, Sylvia Trujillo, Karandeep Singh, Xiaoxuan Liu

Front Digit Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of soil and vegetation in a warm-temperate Pine forest to intensive biomass harvests, phosphorus fertilisation, and wood ash application.
Laurent Augusto, Florent Beaumont, Christophe Nguyen, Jean-Yves Fraysse, Pierre Trichet, David Vidal

Sci Total Environ· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.
Pablo Chicharro, Mar Llamas-Velasco, Susana Armesto, Enrique Herrera Acosta, David Vidal

Dermatol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group.
Vicenç Rocamora, Laura Crespi, Marta Ferran, Mar Llamas-Velasco, Elena Del Alcázar, David Vidal

Dermatol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
Alejandra Reolid, Susana Armesto, Antonio Sahuquillo-Torralba, Tiago Torres, Rosa Feltes, David Vidal

J Am Acad Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric Study on High-Frequency Ultrasound Characterization of Calcium Deposits in Dermal and Subcutaneous Calciphylaxis and Calcinosis.
Marta Gamissans, Priscila Giavedoni, Esther Roe, Julia Sánchez, Monica Quintana-Codina, David Vidal

J Ultrasound Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Pablo Chicharro, Mar Llamas-Velasco, Susana Armesto, Enrique Herrera-Acosta, David Vidal

Dermatol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators.
Russell Burley, Richard C Hewer, Martin Teall, Louise Dickson, Bernardino Ossola, David Vidal

Bioorg Med Chem Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Elena Del Alcázar, Anna López-Ferrer, Álvaro Martínez-Doménech, Ricardo Ruiz-Villaverde, Mª Del Mar Llamas-Velasco, David Vidal

Dermatol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis